Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis.

Dugan KA, Wood MA, Cole MD.

Oncogene. 2002 Aug 29;21(38):5835-43.

2.

New Myc-interacting proteins: a second Myc network emerges.

Sakamuro D, Prendergast GC.

Oncogene. 1999 May 13;18(19):2942-54. Review.

3.

Myc: a weapon of mass destruction.

Secombe J, Pierce SB, Eisenman RN.

Cell. 2004 Apr 16;117(2):153-6. Review.

4.

E2F1 and c-Myc in cell growth and death.

Matsumura I, Tanaka H, Kanakura Y.

Cell Cycle. 2003 Jul-Aug;2(4):333-8. Review.

PMID:
12851485
5.

MYC cofactors: molecular switches controlling diverse biological outcomes.

Hann SR.

Cold Spring Harb Perspect Med. 2014 Jun 17;4(9):a014399. doi: 10.1101/cshperspect.a014399. Review.

6.

Mechanism of transcriptional activation by the Myc oncoproteins.

Cowling VH, Cole MD.

Semin Cancer Biol. 2006 Aug;16(4):242-52. Epub 2006 Aug 4. Review.

PMID:
16935524
7.

Contributions of Myc to tumorigenesis.

Lutz W, Leon J, Eilers M.

Biochim Biophys Acta. 2002 Mar 14;1602(1):61-71. Review.

PMID:
11960695
8.

Myc and its interactors take shape.

Tu WB, Helander S, Pilstål R, Hickman KA, Lourenco C, Jurisica I, Raught B, Wallner B, Sunnerhagen M, Penn LZ.

Biochim Biophys Acta. 2015 May;1849(5):469-83. doi: 10.1016/j.bbagrm.2014.06.002. Epub 2014 Jun 14. Review.

PMID:
24933113
9.

Myc's mastery of mitochondrial mischief.

Morrish F, Hockenbery D.

Cell Cycle. 2003 Jan-Feb;2(1):11-3. Review. No abstract available.

PMID:
12695675
10.

c-Myc in the control of cell proliferation and embryonic development.

Lemaitre JM, Buckle RS, Méchali M.

Adv Cancer Res. 1996;70:95-144. Review. No abstract available.

PMID:
8902055

Supplemental Content

Support Center